Menu Back toAsian Town Hall

DIA 2021 Global Annual Meeting

Asian Town Hall

Session Chair(s)

Nobumasa  Nakashima, PhD

Nobumasa Nakashima, PhD

  • Associate Executive Director for International Programs
  • Pharmaceuticals and Medical Devices Agency (PMDA), Japan
“Regulatory convergence” has been advancing in Asia and expectation to this region as a field of drug development is also increasing. This session shares latest efforts for “regulatory convergence” in Asia and discuss future direction.
Learning Objective : Describe activities to promote convergence in Asian country; Discuss activities based on convergence in Asian country; Discuss findings from FDA’s perspective.


Si Yuan  Zhou

NMPA Perspective

Si Yuan Zhou

  • Deputy Director of CDE, Head of ICH China Office
  • National Medical Products Adminsitration (NMPA), China
Sia  Chong Hock, MSc

ASEAN Convergence in Pharmaceutical Inspections

Sia Chong Hock, MSc

  • Senior Consultant, Audit and Licensing, Director Quality Assurance
  • Health Sciences Authority (HSA), Singapore
Michelle  Limoli, PharmD, RPh

FDA Perspective

Michelle Limoli, PharmD, RPh

  • Senior International Health Science Advisor, Office of the Director, CBER
  • FDA, United States